← All companies
K
Kailera Therapeutics, Inc.
KLRA - Company ID 0002096997
Market cap$2.72 B
Rank#1915
Filings52
Kailera Therapeutics, Inc. has filed 52 public company documents between 2025 and 2026. The most frequent type is new insider ownership (20 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Continue researchKLRA overview$2.72 BMarket cap, financials, charts, and latest company context.
Continue researchMarket cap historyRank #1915See the market value trend behind the filing history.
Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.
Continue researchCompare with LLYPeer viewPut KLRA beside LLY across market cap, revenue, income, and filings.
Similar companies to research next
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.